Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26 16:30 | 8/7/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Fairmount Funds Management LLC | PA | D | 1 | M.d | 996 | 23.60 | 0 | 42 | 11 | 443 | I | |||||||||||||||
8/7/26 20:00 | 8/5/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | CA | O | Chief Me | 4 | M.d | 1,657 | 86.06 | 0 | 19 | 12 | 178 | D | ||||||||||||||
8/7/26 20:00 | 8/5/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | CA | O | Chief Me | 4 | S.d | -1,657 | 86.06 | 0 | -19 | 178 | D | |||||||||||||||
7/10/26 20:00 | 7/8/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Henderson Michael Thomas | CA | DO | CEO | 1 | S | -2,673 | 133.63 | 0 | -20 | 921 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |